and health economics
Market access preparations form the basis of
a successful positioning and launch of new medicines.
Successful market access is crucial to optimising the commercial potential. One of the goals is to ensure that patients who will benefit from the treatment get access to treatment. There is often a trade-off between which patient groups can access the treatment and get reimbursement, and what the price of the medicine should be. For this reason, it is important to develop evidence which can demonstrate the product’s value and which at the same time meets the requirements of authorities and payers.
Evidence-based documentation plays an increasing role in the healthcare sector. Decision-makers demand robust documentation to ensure that medicine and medical equipment are cost-effective and offer the most value for the money, either in the form of direct savings or improved quality of life. Furthermore, decision-makers are increasingly listening to what patients want from their healthcare.
At Incentive, we have vast experience across a wide range of disciplines which support market access for medicine and medical equipment. We help companies strengthen their market access strategies and plans. We help develop evidence to demonstrate and argue for how they can more effectively and efficiently create value for all involved stakeholders.
Market access and price positioning
We help companies strengthen their market access
and price positioning within different areas.
HTA and reimbursement
applications in the
HTA and reimbursement applications in the Nordic countries
Let Incentive help you find your way through all or part of the process
Why choose Incentive?
Read about Incentive’s skills in market access and health economics
Some of the things we help our clients with
Development of market access strategy and plans
We help companies develop market access strategies and plans. We focus on defining the market access ambitions, and how the strategy should be constructed in terms of pricing and reimbursement potentials, and target patient population. Furthermore, we assess the main challenges in the market, requirements from decision-makers and what it takes to meet these requirements and challenges.
We help companies prepare a market access plan for key activities and tactics before a launch. The typical elements of a plan are: a stakeholder analysis and engagement plan, assessment of the need for evidence to accommodate market access challenges, preparation of value communication tools and payer materials as well as preparation of the dialogue with authorities.
Mapping the market access landscape for various illnesses
We help companies map the market access landscape for specific illnesses. This mapping can be used to facilitate the market access strategy and planning.
The needs and demands for the analysis are developed in close collaboration between Incentive and the client. We typically analyse the landscape by investigating what the unmet needs are for the patients. How well are the patients treated with the current treatment options and what treatment guidelines exist? We investigate the competitive environment focusing on both current and future treatment options, and also how current treatments are priced and to which extent reimbursed. We look into the pricing and reimbursement processes and the timelines for market access.
Analyses and documentation of costs
Incentive helps affiliates improve their dialogue with the Medicines Council, Amgros and the Danish Reimbursement Committee, e.g. via cost analyses and examinations of clinical documentation. The cost analyses are carried out in accordance with Amgros’ guidelines for cost analyses and the Danish Medicines Agency’s instructions for carrying out health-economic analyses.
In addition to these analyses, which are targeted at the authorities, we also conduct other cost analyses, which our clients use more widely in their communication with relevant stakeholders.
Development of economic models and analyses
We develop different types of economic models to measure costs, cost-effectiveness and cost-utility, e.g. cost-effectiveness and budget impact models, or we help clients who have existing models with using and adjusting their models. In this way, our work enables our clients to document the effect and value of their products. Furthermore, we assist with conducting health technology assessments (HTAs), and, in a Danish context, mini HTAs. We also facilitate applications and dialogue between authorities and clients in several countries.
Mapping patients’ lives and preferences
Incentive conducts surveys of patients and the public within a range of disease areas. Using the results, we map out quality-of-life ratings, preferences, and willingness and ability to pay.
We analyse patient-reported outcomes (PRO) and patients’ expected quality of life, which is useful information to have when in dialogue with authorities regarding value creation in relation to the price of medicine. The results of many of our projects have been published in scientific journals.
Analyses of register data in Denmark
We use registers or databases to explore the use of healthcare services and prescription medicine as well as to retrieve data on employment, benefits and education. We undertake burden of illness and cost of illness studies to estimate the societal costs of different diseases and treatment options. For instance, we analyse patient/disease prevalence and incidence, age and gender distributions, co-morbidities, risk factors and mortality.
We take our research even further, documenting treatment patterns for different diseases by analysing e.g. development of any use over a length of time and doses in different stages. All analyses aim to improve the understanding of patients’ burden of illness as they navigate the Danish healthcare system.
Literature reviews and publications
We work with clients to publish evidence based on outcomes from e.g. register-based studies, health-economic models, surveys, patient-reported outcomes and literature reviews.
We have helped many companies with communicating complex results and messages in a clear way. We have solid experience in writing manuscripts for publication in peer-reviewed journals. We can also assist in preparing abstracts and posters for scientific conferences.
We provide overviews of the published literature within a disease area, e.g. for a product and relevant comparators to illustrate the burden of illness for a specific disease. The documentation can, among other things, be used for determining a product’s clinical effect and cost-effectiveness and for identifying and generating input data for economic analyses.
We avoid conflicts of interest
Incentive works with stakeholder organisations, public authorities, medico-technical companies and pharmaceutical companies. Some of these are competitors or have conflicting interests in some other fashion.
That is why we only work with one client at a time within a specific field of illness and country as well as indication and patient segment. We consider a project complete when the client has received and approved the final report and we have sent the final invoice. Once we have completed a project in a certain field of illness, field of treatment and patient segment, we can work for another company within the same field, country and segment.
For certain fields of illness and treatment, we enter into a framework contract with an exclusivity clause, which means we do not work with other companies at all.
In the case of projects which do not focus on medical products, such as analyses of quality of life or determinations of the cost of illness for entire patient populations, we can work for several clients at a time.
In very special cases, when Incentive has unique knowledge within a specific disease area, we can work for competing companies. We do this by establishing “Chinese walls” so that two completely different project teams work for the two customers. We ensure full confidentiality, restricted access to drives, data and documents, and under no circumstances do we discuss the projects across project teams.
Read scientific articles, posters and abstracts
Contact a consultant
We are always happy to have a non-committal chat, so please do not hesitate to contact us. We can set up a meeting at your office or online, or you can visit us in Holte or Odense.
Market access and health economics
Market access landscape and strategy, real-world evidence and register-based analyses, health economic modelling, HTA and reimbursement applications, literature reviews, surveys and patient-reported outcomes.
Transport and infrastructure
Cost analyses, business cases, fees and prices, investment analyses, prognoses, pricing, public transport, regulation and market analyses.
Climate and energy
Analyses of climate footprint and initiatives, new regulation, socioeconomics, cost-effectiveness, business cases, investment analyses, climate plans, optimisation potential, taxes and tariffs.
Cost-benefit, cost-effectiveness, internal interest, current value, tax distortion, effects on the state treasury, expenses and taxes.
Pricing excellence, value-based pricing, pricing of new products, design of new price models, optimising discounts and discount policy, and price reviews.
Competition and compensation
Financial compensation calculations, mergers, state support, dominant positioning and intellectual property rights.
BI & Analytics
Analytics, BI, data, what if?, Python, Power BI, mapping, diagnosis, prognosis, recommendation, forecast and tools.